Ernexa Therapeutics Inc. (ERNA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.86M
Last updated: Nov 17, 2026 at 4:10 PM ET
Ernexa Therapeutics Inc. (ERNA) Stock Chart
Ernexa Therapeutics (ERNA) has a latest price of $1.63 on Nov 17, 2026. Its price fell 95.7% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 66.1%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $373,313.34 in Apr 2021 and its lowest $1.97 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ERNA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ERNA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 63.2%, and over 6 months it fell 85.8%. The month-end price fell 99.6% over the 3 years through Oct 2026, a compound annual decline of 84.5%.
| Period | Change |
|---|---|
| 1 month | -17.7% |
| 3 months | -63.2% |
| 6 months | -85.8% |
| 12 months | -95.7% |
| 12 months, with dividends | -95.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -99.6% | -84.5% |
| 5 years | -100.0% | -87.5% |
| 10 years | -100.0% | -66.1% |
Price by Year
Its best calendar year was 2019, when the price rose 12.8%, and its weakest was 2022, when it fell 96.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.97 | -93.4% |
| 2025 | $30.00 | -72.8% |
| 2024 | $110.19 | -83.6% |
| 2023 | $672.79 | -44.3% |
| 2022 | $1,206.90 | -96.1% |
| 2021 | $31,259.37 | -6.9% |
| 2020 | $33,583.21 | +1.8% |
| 2019 | $32,983.51 | +12.8% |
| 2018 | $29,235.38 | -53.7% |
| 2017 | $63,118.44 | -50.5% |
Trading Range
The price is 38.3% below its 50-day average of $2.64 and 71.2% below its 200-day average of $5.65.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.63 | |
| 50-day average | $2.64 | -38.3% |
| 200-day average | $5.65 | -71.2% |
Price Risk
Over 3 years, its largest fall from a peak was 99.8%.
| Measure | Value |
|---|---|
| 1-year beta | 0.75 |
| Largest fall, 1 year | -95.7% |
| Largest fall, 3 years | -99.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ERNA
What is ERNA's 1-year price change?
Ernexa Therapeutics's price fell 95.7% over the past 12 months. With dividends included, the 12-month total return was -95.7%.
What is ERNA's 5-year price change?
Ernexa Therapeutics's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 87.5%. These figures leave out dividends.
What is ERNA's beta?
Ernexa Therapeutics's 1-year beta against the S&P 500 is 0.75, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 95.7%.
Is the ERNA chart free?
Yes. Advanced Charting for ERNA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ERNA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors